The segregation of EPCR and TF-PAR2 expression on subpopulation of human breast cancer cells raised the question whether EPCR made a contribution to tumor growth that was distinct and independent of the established pro-angiogenic effect of TF signaling in breast cancer development [7], [8], [37]. The gene discussed is PROCR; the disease is breast cancer.